Concinnity Genetics
PrivateLast Round
Seed
Dec 16, 2024
Total Funding Raised
$3.79M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Concinnity Genetics is a biotechnology company that develops AI-driven RNA design platforms to build gene control systems for gene and cell therapies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Concinnity Genetics Comparables
Compare Concinnity Genetics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Chromatin Bioscience | 86% | |
| SynGenSys | 85% | |
| aceRNA Technologies Co., Ltd. | 83% |
Concinnity Genetics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Dec 16, 2024 |
Key People
Founding team and executive leadership
Concinnity Genetics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Old College Capital | Seed |
| Eos Advisory | Seed |
| Scottish Investment Bank (Scottish Enterprise) | Seed |
| Maven Capital Partners | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors grew 104% MoM, reaching 1.1K.
- Apr 19, 2026
Monthly visitors grew 190% MoM, from 249 to 722.
Concinnity Genetics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Concinnity Genetics's valuation, stock price, and market status.
Is Concinnity Genetics a public or private company?
Concinnity Genetics is a private company.
What is the current stock price of Concinnity Genetics?
Concinnity Genetics is a private company with no public stock price. No recent secondary market data is available.
How much is Concinnity Genetics worth (valuation)?
Valuation information for Concinnity Genetics is not publicly available.
Can I buy Concinnity Genetics stock?
Concinnity Genetics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Concinnity Genetics's last funding round?
Concinnity Genetics's most recent funding round was Seed on December 16, 2024.
Who are the main investors in Concinnity Genetics?
Key investors in Concinnity Genetics include Eos Advisory.
Will Concinnity Genetics IPO soon?
No public IPO plans have been announced for Concinnity Genetics.
How can I track Concinnity Genetics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Concinnity Genetics's secondary market activity and sign up for updates.